1-(4-methoxyphenyl)pyridinium has been researched along with fullerene c60 in 1 studies
| Studies (1-(4-methoxyphenyl)pyridinium) | Trials (1-(4-methoxyphenyl)pyridinium) | Recent Studies (post-2010) (1-(4-methoxyphenyl)pyridinium) | Studies (fullerene c60) | Trials (fullerene c60) | Recent Studies (post-2010) (fullerene c60) |
|---|---|---|---|---|---|
| 55 | 0 | 1 | 3,806 | 5 | 2,170 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ho, LT; Lay, YP; Lin, AM; Liu, TY; Luh, TY; Ueng, YF; Yang, CH | 1 |
1 other study(ies) available for 1-(4-methoxyphenyl)pyridinium and fullerene c60
| Article | Year |
|---|---|
Differential effects of carboxyfullerene on MPP+/MPTP-induced neurotoxicity.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Apoptosis; Axons; Blotting, Western; Carboxylic Acids; Cytochrome c Group; Cytochrome P-450 Enzyme System; Cytosol; Dopamine; Dopamine Agents; Electrochemistry; Fullerenes; Lipid Peroxidation; Liver; Male; Mice; Microinjections; Neostriatum; Oxidative Stress; Pyridinium Compounds; Rats; Rats, Sprague-Dawley; Substantia Nigra; Tyrosine 3-Monooxygenase | 2004 |